Literature DB >> 15058786

Health-related quality of life in patients with thyroid disorders.

G P Bianchi1, V Zaccheroni, E Solaroli, F Vescini, R Cerutti, M Zoli, G Marchesini.   

Abstract

Limited reports are available on quality of life (HRQL) in thyroid diseases, and no data are available in euthyroid disorders, such as goiter and Hashimoto thyroiditis. Also, asymptomatic patients may suffer a reduction in perceived health status due to distress related to physical appearance and awareness of disease. We measured HRQL by means of Medical Outcome Study Short Form-36 (SF-36) and Nottingham Health Profile (NHP) questionnaires in 368 patients (hypothyroid, 81; hyperthyroid, 45 (for both states including overt and subclinical states); Hashimoto thyroiditis, 51; euthyroid goiter, 191). The final scores of the domains were compared with age- and sex-adjusted Italian normative values, by computing the effect size. All domains of SF-36, except bodily pain, were reduced in thyroid disease; this was mainly the case of role limitation (both physical and emotional), general health and social functioning. The domains of NHP were less severely affected. HRQL was impaired also in the absence of altered hormone levels. Mood/behavior disturbances were present in a large proportion of patients and were significantly associated with poor HRQL. HRQL was significantly reduced in patients with thyroid diseases referred to a secondary level endocrinology unit. Perceived health status may be considered as an additional outcome of management and therapy of thyroid disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15058786     DOI: 10.1023/B:QURE.0000015315.35184.66

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  28 in total

1.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

Authors:  B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

2.  Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?

Authors:  R Jaeschke; G Guyatt; H Gerstein; C Patterson; W Molloy; D Cook; S Harper; L Griffith; R Carbotte
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

4.  The impact of diagnosis of hepatitis C virus on quality of life.

Authors:  A J Rodger; D Jolley; S C Thompson; A Lanigan; N Crofts
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

5.  [Epidemiology of endemic goiter in Italy].

Authors:  F Aghini-Lombardi; L Antonangeli; P Vitti
Journal:  Ann Ist Super Sanita       Date:  1998       Impact factor: 1.663

6.  Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.

Authors:  M N Gerding; C B Terwee; F W Dekker; L Koornneef; M F Prummel; W M Wiersinga
Journal:  Thyroid       Date:  1997-12       Impact factor: 6.568

7.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

8.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

Authors:  G Apolone; A Filiberti; S Cifani; R Ruggiata; P Mosconi
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

9.  Effect sizes for interpreting changes in health status.

Authors:  L E Kazis; J J Anderson; R F Meenan
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

10.  Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism.

Authors:  M Bommer; T Eversmann; R Pickardt; A Leonhardt; D Naber
Journal:  Klin Wochenschr       Date:  1990-06-05
View more
  49 in total

1.  Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement.

Authors:  Marina Djurovic; Alberto M Pereira; Johannes W A Smit; Olga Vasovic; Svetozar Damjanovic; Zvezdana Jemuovic; Dragan Pavlovic; Dragana Miljic; Sandra Pekic; Marko Stojanovic; Milika Asanin; Gordana Krljanac; Milan Petakov
Journal:  Endocrine       Date:  2018-06-29       Impact factor: 3.633

2.  An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.

Authors:  Sarah J Peterson; Anne R Cappola; M Regina Castro; Colin M Dayan; Alan P Farwell; James V Hennessey; Peter A Kopp; Douglas S Ross; Mary H Samuels; Anna M Sawka; Peter N Taylor; Jacqueline Jonklaas; Antonio C Bianco
Journal:  Thyroid       Date:  2018-04-05       Impact factor: 6.568

3.  Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.

Authors:  Celestino Pio Lombardi; Raffaella Bocale; Angelina Barini; Antonella Barini; Annamaria D'Amore; Mauro Boscherini; Rocco Bellantone
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

4.  Endocrine and Metabolic Disorders in Survivors of Childhood Cancers and Health-Related Quality of Life and Physical Activity.

Authors:  Kamnesh R Pradhan; Yan Chen; Sogol Moustoufi-Moab; Kevin Krull; Kevin C Oeffinger; Charles Sklar; Gregory T Armstrong; Kirsten K Ness; Leslie Robison; Yutaka Yasui; Paul C Nathan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

5.  Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study.

Authors:  Anjali Mishra; Mayilvaganan Sabaretnam; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

6.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

7.  Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.

Authors:  M H Samuels; K G Schuff; N E Carlson; P Carello; J S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

8.  Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing.

Authors:  Torquil Watt; Ase Krogh Rasmussen; Mogens Groenvold; Jakob Bue Bjorner; Sara Hope Watt; Steen Joop Bonnema; Laszlo Hegedüs; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2008-06-27       Impact factor: 4.147

9.  Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study.

Authors:  Patrícia dos Santos Vigário; Fernanda Vaisman; Cláudia Medina Coeli; Laura Ward; Hans Graf; Gisah Carvalho; Renan Montenegro Júnior; Mário Vaisman
Journal:  Endocrine       Date:  2013-01-31       Impact factor: 3.633

10.  The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.

Authors:  Mary H Samuels; Irina Kolobova; Anne Smeraglio; Dawn Peters; Jeri S Janowsky; Kathryn G Schuff
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.